NCT03113188 2021-03-10CBP501, Cisplatin and Nivolumab in Advanced Refractory TumorsCanBas Co. Ltd.Phase 1 Completed47 enrolled
NCT00551512 2017-03-14Phase I Study of CBP501 and Cisplatin in Patients With Advanced Refractory Solid TumorsCanBas Co. Ltd.Phase 1 Completed48 enrolled